The growth for Vertex’s Journavax painkiller is just beginning to ramp up, given the potential size of the nonaddictive drug market. The AI rally has many investors wondering where to turn in ...

RFT Writers are a collective of independent journalists contributing original reporting to RFT. They report on a wide range of topics including music, news, gaming, cannabis, and the creator economy.